Prevention and Treatment for Covid-19 Assoiated Severe Pnuemonia in The Gambia: A randomized clinical Trial - Funded by UKRI

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-112

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Professor Anna Roca
  • Research Location

    Gambia
  • Lead Research Institution

    MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The study intends to evaluate the efficacy of a  chosen drug in preventing progression to severe pneumonia, and to evaluate the efficacy of prophylactic chosen drug in preventing COVID19 infection among house hold contacts (both symptomatic and asymptomatic).